SNCA and Cognitive impairment: Patients with Parkinson’s disease carrying mutations in the gene for synuclein, SNCA, also show higher rates of cognitive deficits, REM sleep behaviour disorder (RBD) and hallucinations (Nishioka et al., 2009; Konno et al., 2016; Petrucci et al., 2016).